TAK·874060205·US·ADR·Healthcare - Drug Manufacturers - Specialty & Generic
TAK (TAKEDA PHARMACEUTICAL CO LTD) is held by 122 institutional investors as of Q1 2026. Largest holders: Capital Research Global Investors ($353.8M), FMR LLC ($131.8M), MORGAN STANLEY ($119.8M). Net institutional sentiment: Bullish.
Showing 1-20 of 134
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer